GABAERGIC ANTIDEPRESSANTS
MODELS BASED ON THE LEARNED HELPLESSNESS HYPOTHESIS
THE DRL ANTIDEPRESSANT SCREEN
MODELS RELATING TO SEROTONERGIC DRUGS
SENSITIZATION OF DOPAMINERGIC NEUROTRANSMISSION AS A NEW TARGET FOR ANTI-DEPRESSANT THERAPY
BEHAVIOURAL DISPAIR SYNDROME
NEUROPHARMACOLOGY OF DEPRESSION
DIURNAL RHYTHMS OF HYPOTHALAMIC NEUROCHEMICAL CONTROL OF NUTRIENT INGESTION
THE USE OF MELATONIN AS A STRATEGY FOR ASSESSING AND TREATING CHRONOBIOLOGIC MOOD DISORDERS
ANTIDEPRESSANT EFFECTS OF SLEEP DEPRIVATION
SINGLE PHOTON EMISSION TOMOGRAPHY WITH 99MTC-EXAMETAZIME IN MAJOR DEPRESSION AND THE PATTERN OF BRAIN ACTIVITY UNDERLYING THE ENDOGENOUS/ NEUROTIC CONTINUUM
IS ANXIETY ASSOCIATED WITH A HYPER- OR HYPO-SEROTONERGIC STATE?
CRITICAL ISSUES IN NOOTROPIC DRUG RESEARCH
GLUTAMATERGIC RECEPTORS AND LEARNING - METHODOLOGICAL ASPECTS
“IN SEARCH OF THE ENGRAM”
DRUGS, NEUROTRANSMITTERS AND OFFENSIVE AGGRESSION
DEFENSE AND SUBMISSION
USE OF SOCIAL BEHAVIOUR AND CONDITIONED PERFORMANCE FOR EVALUATING ANXIOLYTIC DRUGS
NEUROENDOCRINE DETERMINANTS OF MOTIVATION AND PERFORMANCE IN MALE SEXUAL BEHAVIOUR
RAT PUP ISOLATION CALLS
ANXIOLYTICS
USING ANTIPREDATOR DEFENSIVE BEHAVIORS TO SCREEN FOR THE ACTIONS OF CNS COMPOUNDS IN THE MODULATION OF FEAR AND ANXIETY
SEROTONIN SPECIFIC DRUGS FOR THE TREATMENT OF AFFECTIVE AND ANXIETY DISORDERS
5HT SUB-SYSTEMS IN ANXIETY, PANIC AND DEPRESSION
ECT
THE POSSIBLE ROLE OF SEROTONIN RECEPTOR SUBTYPES IN PSYCHIATRIC SYNDROMES
EFFECTS OF ACTH NEUROPEPTIDES ON CNS LESIONS
EFFECTS OF ACTH NEUROPEPTIDES ON NERVE REPAIR AND NEUROPATHY, ANIMAL AND HUMAN STUDIES
EFFECTS OF THE ACTH(4–9) ANALOG ORG 2766 IN THE AGING RAT
EFFECTS OF ACTH NEUROPEPTIDES ON DEVELOPING AND REGENERATING MOTOR SYSTEMS
GENETIC DIFFERENCES IN EMOTIONALITY AS A STRATEGY, RATHER THAN COMPLICATING FACTOR, FOR STUDYING CNS ACTIVE COMPOUNDS
STRAIN-RELATED DIFFERENCES IN GABAERGIC AND DOPAMINERGIC TRANSMISSION IN ROMAN HIGH AVOIDANCE AND ROMAN LOW AVOIDANCE RATS
PSYCHOBIOLOGICAL AND PSYCHOPHARMACOLOGICAL STUDIES OF ROMAN RAT LINES
LONG-LASTING ENVIRONMENTAL EFFECTS ON BEHAVIOR OF PSYCHOGENETICALLY-SELECTED RATS WITH DIVERGENT EMOTIONALITY
GENETIC DIFFERENCES IN ANIMAL MODELS OF ANXIETY
PRECLINICAL EFFICACY EVALUATION OF PROPOSED MEDICATIONS FOR DRUG ABUSE TREATMENT
NEURAL BASIS OF DRUG-INDUCED REWARD
SUBSTITUTED PHENETHYLAMINE NEUROTOXICITY
THE REINFORCING EFFECTIVENESS OF DRUGS
INTERACTIONS BETWEEN OPIOIDS AND STIMULANTS
DEPENDENCE AND OPIOID ANALGESIA
PRECLINICAL BEHAVIORAL DIFFERENCES BETWEEN COMPETITIVE AND PHENCYCLIDINE-LIKE NMDA ANTAGONISTS THAT MIGHT PREDICT DIFFERENCES IN CLINICAL EFFECTS
THE STIMULUS EFFECTS OF ANXIOLYTICS RELATED TO ABUSE
DEPENDENCE ASPECTS OF ANXIOLYTIC DRUGS
EFFECTIVENESS OF TREATMENT FOR ALCOHOLISM AND OTHER FORMS OF DRUG DEPENDENCE
SEROTONERGIC COMPOUNDS IN THE TREATMENT OF ALCOHOLISM
REPRODUCTIVE BEHAVIORS IN PRENATALLY ETHANOL EXPOSED OFFSPRING
DIFFERENTIAL EFFECTS OF TYPICAL AND ATYPICAL NEUROLEPTICS ON APPETITIVE AND DEFENSIVE BEHAVIORS
A POTENTIAL ROLE FOR NEUROTENSIN IN MEDIATING THE THERAPEUTIC EFFECTS OF ANTIPSYCHOTIC DRUGS
COMPARISON OF TYPICAL AND ATYPICAL NEUROLEPTICS IN THE MORRIS SWIM MAZE
ROLE OF OLFACTORY TUBERCLE AND NUCLEUS ACCUMBENS IN THE EFFECTS OF CLASSICAL AND ATYPICAL NEUROLEPTICS
SERTINDOLE - AN ATYPICAL NEUROLEPTIC
POSSIBLE MECHANISMS UNDERLYING THE ATYPICAL NEUROLEPTIC PROFILE OF THE SELECTIVE DA D, RECEPTOR ANTAGONISTS REMOXIPRIDE AND RACLOPRIDE
CLINICAL CHARACTERISTICS OF ATYPICAL ANTIPSYCHOTIC DRUGS
VALIDITY OF ANIMAL, MODELS AND THE EVALUATION OF ANTIPSYCHOTIC DRUGS
PRECLINICAL EVIDENCE FOR THE ANXIOLYTIC POTENTIAL OF E-4424
ELECTROPHYSIOLOGY IN THE DEVELOPMENT OF SCREENS AND FOR UNDERSTANDING OF MECHANISMS OF ACTION OF ANTIPSYCHOTIC DRUGS
PERSPECTIVES ON BASAL FOREBRAIN ORGANIZATION AND PSYCHOTIC DISORDERS
REGULATION OF DOPAMINE D2 RECEPTORS
REMOXIPRIDE
PET SCANNING OF DOPAMINE RECEPTORS AND PSYCHOSIS
RISPERIDONE
WHY DO WE NEED NEW ANXIOLYTICS?
5-HT RECEPTOR TYPES AND ANXIETY
PRECLINICAL EVIDENCE FOR THE ANXIOLYTIC POTENTIAL OF E-4424
ELECTROPHYSIOLOGICAL EVIDENCE FOR THE AGONIST PROPERTIES OF THE NEW POTENTIAL ANXIOLYTIC DRUG E-4424 ON SOMATODENDRITIC 5-HT1A AUTORECEPTORS
CNS PROFILE OF LESOPITRON, A NEW 5-HT1A RECEPTOR LIGAND
THE MPTP-INDUCED PARKINSONIAN DISORDER
INTERACTION BETWEEN NMDA RECEPTOR ANTAGONISTS AND DOPAMINERGIC AGONISTS IN THE 6-HYDROXYDOPAMINE MODEL OF PARKINSON
EFFECTS OF GROWTH FACTORS ON CATECHOLAMINE CELLS
6-HYDROXYDOPAMINE INDUCED MOTOR DYSFUNCTION
ENDOGENOUS EXCITOTOXINS AND ANTIEXCITOTOXINS IN NEURODEGENERATIVE BRAIN DISEASES
AGING AND THE CELLULAR MECHANISMS OF BASAL GANGLIA DISEASES, ESPECIALLY PARKINSON'S DISEASE
PARKINSONS DISEASE (PD) - POSITRON EMISSION TOMOGRAPHY (PET), PHARMACOKINETICS AND THERAPEUTIC STRATEGIES
BASAL GANGLIA MECHANISMS INVOLVED IN MOVEMENT DISORDERS
INTRINSIC ORGANIZATION OF THE NIGROSTRIATAL SYSTEM IN RELATION TO DISEASES OF THE BASAL GANGLIA
HUNTINGTONS CHOREA AND COGNITIVE DISORDERS
MOTIVATIONAL MEASURES OF DRUG DEPENDENCE
DOPAMINE TRANSPORTER AS A COCAINE RECEPTOR
BEHAVIOURAL PHARMACOLOGY OF TASTE HEDONICS
DOPAMINE AND REWARD-RELATED LEARNING
EFFECTS OF MANIPULATION OF CENTRAL CHOLINERGIC NEURONS ON TESTS OF LEARNING, MEMORY AND ATTENTION
EFFECTS OF DRUGS ON CLASSICAL CONDITIONING
COGNITIVE EFFECTS OF BENZODIAZEPINE AGONISTS AND INVERSE AGONISTS IN HUMANS AND RATS
ANIMAL MODELS OF MEMORY
THE NEUROTRANSMITTER SYSTEMS INVOLVED IN MEMORY CONSOLIDATION
THE MEMORY-IMPROVING ACTION OF STRIATAL DOPAMINE AUTORECEPTOR ACTIVATION
EVALUATION OF PHARMACOLOGICAL AGENTS FOR UTILITY AS COGNITIVE ENHANCERS
CLINICAL FEATURES OF ALZHEIMER'S DISEASE
HIPPOCAMPAL ATROPHY
SEMANTIC MEMORY DEFICITS IN PATIENTS WITH DEGENERATIVE DISEASE
NEUROTRANSMITTER BASES AND TREATMENT OF DEPRESSION IN ALZHEIMERS AND PARKINSON'S DISEASE
ANIMAL MODELS OF DRUG WITHDRAWAL SYMPTOMS
STUDIES OF BEHAVIORAL DEPENDENCE
BEHAVIOURAL CONSEQUENCES OF WITHDRAWAL FROM DRUGS OF ABUSE
DISCRIMINATIVE STIMULUS EFFECTS OF OPIOID ANTAGONISTS AS A MEASURE OF OPIOID WITHDRAWAL
(S)-UH-301, A NOVEL 5-HT1A RECEPTOR ANTAGONIST
EFFECTS OF ANTIDEPRESSANT DRUGS ON THE SEROTONERGIC SYSTEM
LEARNED HELPLESSNESS
EFFECT OF ANTIDEPRESSANT DRUGS ON THE SEROTONERGIC SYSTEM
INSOMNIA AND AFFECTIVE DISORDERS
LITHIUM RATIO, PHOSPHOLIPIDS AND THE INCIDENCE OF SIDE EFFECTS
UNIQUE EFFECTS OF PAROXETINE, A NEW SSRI ANTIDEPRESSANT, ON SLEEP ANXIETY AND COGNITION
LATERALIZATION OF TINNITUS AND ITS RELATION TO DEPRESSION
STRESS, DEPRESSION AND THE CENTRAL OPIOID SYSTEM
PRIOR EXPOSURE TO AMPHETAMINE ENHANCES VOLUNTARY INTAKE OF ETHANOL IN THE RAT
PSYCHOPATHOLOGICAL PROFILE IN ANXIETY DISORDERS
RITANSERIN, A NEW THERAPEUTIC APPROACH FOR DRUG ADDICTION
BENZODIOXEPIPERAZINE DERIVATIVES AS NOVEL 5-HT1A ANTAGONISTS
COMMON FUNCTIONAL CORRELATES OF NMDA RECEPTOR ANTAGONISM AND 5− HT1A RECEPTOR AGONISM
ON THE SITE OF ACTION OF ELTOPRAZINE, TFMPP AND 8-OH-DPAT IN REDUCING AGGRESSION IN RATS
EFFECTS OF ELTOPRAZINE AND HALOPERIDOL ON AGGRESSION IN MALE RATS AFTER CHRONIC ADMINISTRATION
THE GROWTH HORMONE-RELEASING HORMONE (GHRH)-TEST IN DEPRESSION AND OTHER PSYCHIATRIC DISORDERS. CLINICAL SIGNIFICANCE AND PATHOPHYSIOLOGIC IMPLICATIONS
BEHAVIOURAL PHARMACOLOGY OF THE 5-HT1A AGONIST FLESINOXAN
THE FLINDERS SENSITIVE LINE RAT
DIAZEPAM AND BUSPIRONE DIFFERENTIALLY INTERFER WITH “ANXIOGENIC” DRUGS IN A SAFETY SIGNAL WITHDRAWAL PARADIGM OF CONFLICT BEHAVIOUR IN RATS
PERINATAL FLUMAZENIL (RO 15–1788) EFFECTS ON ADULT EXPLORATION AND TWO-WAY ACTIVE AVOIDANCE IN ROMAN HIGH- AND LOW-AVOIDANCE RATS
DISCRIMINATIVE STIMULUS EFFECT OF THE SERENIC ELTOPRAZINE
ACUTE EFFECTS OF (R)-8-OH-DPAT AND A NOVEL 5-HT1A RECEPTOR ANTAGONIST, UH-301, ON THE CELL FIRING OF DORSAL RAPHE (DRN) 5-HT NEURONS AND DA NEURONS IN THE VENTRAL TEGMENTAL AREA (VTA)
STRUCTURE-ACTIVITY RELATIONSHIP STUDIES ON SOME INDOLALKYLAMINES ACETYLENIC DERIVATIVES AS SELECTIVE MAO-A INHIBITORS
ROLE OF CCK-A AND CCK-B RECEPTORS IN LOCOMOTION, THIGMOTACTIC SCANNING, CONFLICT BEHAVIOR AND ANXIETY
SEX DIFFERENCES IN ANTIPREDATOR DEFENSIVE REACTIONS AND IN REACTIONS TO ANXIOLYTIC DRUGS
ACUTE EFFECTS OF LOW DOSES OF CLOMIPRAMINE ON ISOLATION-INDUCED AGGRESSION IN MALE MICE
COMPARATIVE STUDY ON THE MINIMUM LETHAL DOSE AND CARDIOTOXIC EFFECTS OF SIFAPRAZINE, DELFAPRAZINE, IMIPRAMINE AND AMITRIPTYLINE IN THREE ANIMAL SPECIES
PSYCHOLOGICAL AND SOMATIC DISTRESS IN RELATION TO PERCEIVED HEARING DISABILITY, HEARING HANDICAP, AND HEARING MEASUREMENTS
DOSE-DEPENDENT EFFECTS OF MORPHINE ON AGONISTIC BEHAVIOUR IN MALE MICE
IMIPRAMINE AND DESIPRAMINE REDUCE THE GABA-STIMULATED CHLORIDE UPTAKE, AND CHLORIDE-CHANNEL ANTAGONISTS INCREASE THEIR ANTI- IMMOBILITY ACTION IN THE FORCED SWIMMING TEST IN RATS
PANCOPRIDE, A NEW 5-HT3 ANTAGONIST WITH POTENT ANXIOLITIC PROPERTIES IN RODENTS AND PRIMATES
EFFECTS OF ALPRAZOLAM ON PLASMATIC BETA-ENDORPHIN, ALPHA-MSH, ACTH AND VtASOPRESSIN UNDER IMMOBILIZATION STRESS AND CONFLICT TEST PARADIGM IN RATS
THE EFFECTS OF D-AMPHETAMINE, DIAZEPAM AND BUSPIRONE ON PUNISHED SCHEDULE-INDUCED DRINKING
CHOLECYSTOKININ-INDUCED SUPPRESSION OF SUCROSE SHAM FEEDING IN THE RAT IS BLOCKED BY EITHER L-365, 260 OR DEVAZEPIDE
INTRACEREBROVENTRICULAR CRH (CORTICOTROPIN-RELEASING HORMONE) REDUCES THE IMMOBILITY IN THE FORCED SWIMMING TEST (FST)
LIGHT THERAPY IN DEPRESSED PATIENTS AND CONTROLS, EFFECTS ON SLEEP
BEHAVIORAL AND BIOCHEMICAL VARIATIONS INDUCED BY STRESS AS PROBES TO DETECT DRUGS THAT INTERFERE WITH ACTH PITUITARY SECRETION
FEAR-POTENTIATED STARTLE IN ADULT RATS AND SEPARATION-INDUCED VOCALIZATIONS IN RAT PUPS
POTENTIATION OF ESERINE-INDUCED LETHALITY IN MICE
COGNITIVE BIAS AS AN OUTCOME MEASURE IN THE TREATMENT OF DEPRESSION
THE USE OF BRIGHT LIGHT IN WINTER DEPRESSION
SUCCESSIVE NEGATIVE CONTRAST EFFECT IN ONE-WAY AVOIDANCE LEARNING
A COMPARISON OF THE EFFECTS OF D-FENFLURAMINE AND PRE-SATIATION ON THE MICROSTRUCTURE OF LICKING FOR WATER
SWEETNESS-DEPENDENT SUPPRESSION OR FACILITATION OF SUCROSE DRINKING
NEURAL DOPAMINERGIC ACTIVITY IN ANIMALS WITH DIFFERENT LEVEL OF GENETICALLY DETERMINED DEFENSIVENESS
PRETREATMENT WITH THE NOVEL 5-HT1A RECEPTOR ANTAGONIST UH-301 PREVENTS 8-OH-DPAT-INDUCED DECREASE IN INTERSTITIAL CONCENTRATIONS OF SEROTONIN IN THE RAT HIPPOCAMPUS
PHARMACOLOGICAL PROFILE OF THE POTENTIAL NEW ANTIDEPRESSANT, SIFAPRAZINE
THE ROLE OF ACCUMBENS SEROTONERGIC INNERVATION IN EMOTIONAL BEHAVIOUR
DIFFERENT DEVELOPMENT OF TOLERANCE TO ANTI AGGRESSIVE AND MOTOR EFFECTS OF HALOPERIDOL
ATTENUATION OF PLACE PREFERENCE CONDITIONING BY CHRONIC UNPREDICTABLE MILD STRESS
EFFECTS OF A FENUGREEK SEED EXTRACT ON FEEDING BEHAVIOUR IN THE RAT
NEUROPRARMACOLOGICAL EFFECTS OF FG5893
THE DIFFERENTIAL EFFECTS OF EXCITATORY AMINO ACIDS ON CYCLIC AMP ACCUMULATION IN RATS, THE INFLUENCE OF PROLONGED ANTIDEPRESSANT TREATMENT
EFFECTS OF ACUTE AND CHRONIC STRESSORS ON SACCHARIN PREFERENCE IN HYPERCHOLINERGIC RATS
DIURNAL VARIATION OF MOOD AND SLEEP DEPRIVATION IN DEPRESSED PATIENTS
BEHAVIORAL MECHANISM OF THE EFFECTS OF DESIPRAMINE ON THE DRL 72-S ANTIDEPRESSANT SCREEN
THE BUSPIRONE CUE
ON THE BEHAVIOURAL SELECTIVITY OF ‘SERENICS’
DEPRESSIVE SYMPTOMS IN THE ANOREXIA NERVOSA'S COURSE
EFFECT OF PRENATAL EXPOSURE TO ANTIDEPRESSANTS ON SEROTONIN-STIMULATED INOSITOL PHOSPHATE FORMATION IN RAT CEREBRAL CORTEX
“DESPERSONALIZATION”, “DESREALIZATION”, AUTOAGGRESSION IN AFFECTIVE DISORDERS
NEW MODEL OF WATER MAZE - METHOD FOR STUDING SPATIAL MEMORY
A NEW CHRONOBIOLOGICAL MODEL OF DEPRESSION
CALCIUM CHANNEL BLOCKERS MODULATE BEHAVIOURAL EFFECTS OF BENZODIAZEPINES IN AN ANIMAL MODEL OF ANXIETY
IS MEMORY INVOLVED IN THE FORCED SWIMMING TEST?
CHARACTERIZATION OF THE PUTATIVE 5-HT RECEPTOR ANTAGONISTS BMY 7378 AND NAN-190 IN ANIMAL MODELS REFLECTING 5-HT1A RECEPTOR ACTIVITY
COMPARISON OF THE ANXIOLYTIC AND ANTIDEPRESSIVE EFFECTS OF DIAZEPAM, IMIPRAMINE AND THE 5-HT1A RECEPTOR LIGANDS IPSAPIRONE AND-OH-DPAT AFTER REPEATED ADMINISTRATION IN THE RAT
ANXIOLYTIC EFFECTS OF IPSAPIRONE IN THE RAT CORRELATE WITH INHIBITION OF DORSAL RAPHE CELL FIRING AND DECREASE IN 5-HT NEUROTRANSMISSION IN THE DORSAL HIPPOCAMPUS
THE ROLE OF SEROTONIN IN COMPULSIVE BEHAVIOR
STUDY ON THE INVOLVEMENT OF NON-SEROTONERGIC SYSTEMS IN THE DISCRIMINATIVE STIMULUS OF THE 5-HT1A AGONIST FLESINOXAN
COMPARATIVE PHARMACOLOGICAL STUDIES OF THE STEREOISOMERS OF 8-OH DPAT AND LY-41, A NEW 5-HT1A AGONIST
THE EFFECT OF 3-AMINO-1, 2, 4-TRIAZOLE ON VOLUNTARY ETHANOL CONSUMPTION
SUICIDAL THOUGHTS AND BEHAVIOUR (SUICIDALLY) WITH PAROXETINE
LOW DOSES OF MORPHINE AND OF NALTREXONE REDUCE ALCOHOL INTAKE IN RHESUS MONKEYS
POTENTIAL HAZARDS OF BENZODIAZEPINES FOR THE FOETUS
ONTOGENETIC TREND OF COCAINE HYPERACTIVITY AND CONDITIONED PLACE PREFERENCE IN MICE
GENOTYPIC VARIATIONS IN ETHANOL'S PHARMACOLOGIC PROFILE AND ITS RELATION TO INHIBITORY AND EXCITATORY NEUROTRANSMITTERS
PILOT PRECLINICAL STUDY ABOUT INTRATHECAL ADMINISTRATION OF NALTREXONE HYDROCHLORIDE BY IMPLANTABLE INFUSION PUMPS
ABUSE DRUG ASSOCIATION TOXICITY IN THE MOUSE
LACK OF TOLERANCE AND PHYSICAL DEPENDENCE AFTER TREATMENT WITH ALPIDEM, A NEW IMIDAZOPYRIDINE ANXIOLYTIC, IN MICE
FAWN HOODED RATS WITH GENETIC 5-HT IMPAIRMENT
PRESENCE OF CANNABINOID BINDING SITES IN THE BRAIN AT EARLY AGES OF DEVELOPMENT
RELAPSE TO OPIATE USE PROVOKES DUAL CHANGES OF BLOOD PRESSURE IN HEROIN-WITHDRAWN ADDICTS TREATED WITH CLONIDINE
ANTICONVULSANT EFFECTS OF THE CALCIUM CHANNEL ANTAGONIST NIFEDIPINE ON COCAINE-INDUCED CONVULSIONS IN MICE
AN ANIMAL MODEL OF ALCOHOLISM DEVELOPED IN THE MALE RAT
ALCOHOL AND ABUSED DRUGS
GRP-INDUCED GH RESPONSE IN OPIATE ADDICTS
MULTIPLE DRUG USE AMONG THE GENERAL POPULATION OF SPAIN
INHIBITION BY CALCIUM ANTAGONISTS OF CLONIDINE ABSTINENCE PRECIPITATED BY YOHIMBINE IN VITRO AND IN VIVO
SYSTEMIC NICOTINE EVOKES ELEVATED EXTRACELLULAR DOPAMINE IN THE NUCLEUS ACCUMBENS BY VOLTAGE-DEPENDENT MECHANISMS
SOME BEHAVIORAL CORRELATES OF ETHANOL-SEEKING BEHAVIOR IN RATS CONDITIONED PLACE PREFERENCE IN THE COMMON MARMOSET (CALLITHRIX JACCHUS)
ALCOHOLISM AND MNSS GENETIC MARKER
IN VITRO MEASUREMENT OF FUNCTIONAL N-METHYL-D-ASPARTATE RECEPTOR RESPONSES IN BRAIN MEMBRANES
MORPHINE DECREASES BODY WEIGHT IN MALE MICE
EFFECTS OF ADRENALECTOMY AND SUBSEQUENT CORTICOSTERONE TREATMENT ON ETHANOL CONSUMPTION IN MALE WISTAR RATS
ABSENCE OF ACUTE OR RAPID TOLERANCE TO CUE PROPERTIES OF 8-OH-DPAT
FURTHER EVALUATION OF AN OPIOID WITHDRAWAL SYNDROME IN RATS
5HT, RECEPTOR SYSTEM AND ETHANOL DEPENDENCE IN RATS
RELATIONSHIPS BETWEEN FREE ACQUISITION OF ALCOHOL DRINKING AND HORMONAL STATUS IN RHESUS MONKEYS
MODIFICATION IN THE DEVELOPMENT OF MORPHINE DEPENDENCE IN RATS BY ELECTROLYTIC LESIONS OF THE LOCUS COERULEUS
OME ASPECTS OF BUSPIRONE-ETHANOL INTERACTION IN CHRONICALLY ETHANOL TREATED RATS
PHARMACOLOGICAL ASPECTS OF WITHDRAWAL TO CERTAIN BENZODIAZEPINES
VOLUNTARY ETHANOL DRINKING INCREASES THE LOCOMOTOR ACTIVITY OF ALCOHOL-PREFERRING AA RATS
EFFECTS OF LIMITED ACCESS, FOOD-DEPRIVATION AND SOLUTION PALATABILITY ON ORAL ETHANOL SELF-ADMINISTRATION IN RATS
A COMPARISON OF DIFFERING INTENSITIES OF STIMULUS CUES IN ETONITAZENE PLACE CONDITIONING IN C57BL/6J MICE
INTERACTIONS BETWEEN ETHANOL AND R015–4513 IN THE “PLUS MAZE” TEST AND IN TWO-WAY ACTIVE AVOIDANCE ACQUISITION
DIFFERENTIAL EFFECTS OF L-, T- AND N-TYPE CALCIUM CHANNEL ANTAGONISTS ON MORPHINE ABSTINENCE PRECIPITATED BY NALOXONE IN RAT ILEUM
MK801 ENHANCES THE SEROTONIN DEPLETIONS INDUCED BY FENFLURAMINE
DOPAMINERGIC SENSITIVITY IN ALCOHOLISM
THE INFLUENCE OF CARBAMAZEPINE ON THE LOCOMOTOR ACTIVITY IN RATS IN STATE OF TOLERANCE OF SOME BENZODIAZEPINES
CARBAMAZEPINE IN BENZODIAZEPINE WITHDRAWAL
TOLERANCE TO CUE PROPERTIES OF COCAINE FOLLOWING CHRONIC GBR12909 TREATMENT
NOVEL ASPECTS OF ADENOSINE-DOPAMINE INTERACTIONS
LORAZEPAM
INCREASED DURATION AND EFFICACY OF HALOPERIDOL- OR RACLOPRIDE-INDUCED EFFECTS ON TREADMILL LOCOMOTION IN THE RAT BY REPEATED TESTING
NEONATAL 6-HYDROXYDOPAMINE LESIONS IN RATS AS A DOPAMINE- DEPENDENT SCHIZOPHRENIA-MODEL
CONDITIONED PLACE AVERSION INDUCED BY SEROTONIN 5-HT1C RECEPTOR ANTAGONISTS
MARIJUANA SMOKING AND CEREBRAL BLOOD FLOW
CHANGES IN CEREBRAL BLOOD FLOW AFTER DIAZEPAM EVALUATED WITH 3 MEASUREMENT TECHNIQUES
ANTAGONISM BY 8-OH-DPAT, BUT NOT RITANSERIN, OF CATALEPSY PRODUCED BY RACLOPRIDE OR SCH 23390 IN RATS
BEHAVIOURAL PHARMACOLOGY OF AMPEROZIDE, A NEW ANTIPSYCHOTIC DRUG WITH A SELECTIVE LIMBIC MODE OF ACTION
EFFECTS OF HALOPERIDOL ON ESCAPE-AVOIDANCE BEHAVIOUR IN OVARIECTOMIZED MICE
EFFICACY, SAFETY AND TOLERABILITY OF AMPEROZIDE IN ACUTE SCHIZOPHRENIA
FG5803
A 5-CHOICE SERIAL REACTION TIME TASK AS A TOOL WITHIN PSYCHOPHARMACOLOGY
MK-801 GIVEN IN COMBINATION WITH SUBSTITUTED PHENETHYLAMINES DECREASES CORE BODY TEMPERATURE IN RATS
INDIVIDUAL DIFFERENT RESPONSES OF APOMORPHINE-TREATED RATS TO NEUROLEPTIC DRUGS
PARTICIPATION OF GABAA RECEPTORS OF THE GLOBUS PALLIDUS(GP) AND LATERAL HYPOTHALAMUS-ZONA INCERTA REGION (LH-Zl) IN THE NEUROLEPTIC-INDUCED CATALEPSY
DOES HALOPERIDOL PRODUCE A TIME-DEPENDENT SENSITIZATION OF CATALEPSY IN MALE MICE?
EFFECT OF APOMORPHINE ON CONFLICT-INDUCED STEREOTYPIES IN BANK VOLES
SCHEDULE INDUCED POLYDIPSIA (SIP)
COMPARISON OF THE EFFECTIVITY OF INDIVIDUALLY ADAPTED AND STANDARDIZED DOSAGES OF HALOPERIDOL
THE ROLE OF DOPAMINE RECEPTORS OF THE LATERAL HYPOTHALAMUS-ZONA INCERTA REGION (LH-ZI) IN THE NEUROLEPTIC-INDUCED CATALEPSY
“SCHIZOPHRENIA” IN ENCEPHALITIS
INDUCED RECOVERY OF FORCE CAPACITY AFTER LESIONS OF THE FORELIMB PRIMARY MOTOR CORTEX, REPRESENTATION OF THE RAT
BASAL GANGLIA NEUROPEPTIDE ALTERATIONS IN PARKINSON'S DISEASE AND CONTROLS BEARING LEWY BODIES
DOPAMINE AND SEROTONIN DEPLETION IN THE BRAIN OF MARMOSETS PRENATALLY EXPOSED TO MPTP
LONG LATENCY REFLEX AND RIGIDITY IN PARKINSON'S DISEASE
APPLICATION OF LOCOMOTOR ANALYSIS TO THE STUDY OF CNS ACTIVE COMPOUNDS IN THE RAT
NOVEL ASPECTS OF ADENOSINE-DOPAMINE INTERACTIONS
STUDIES ABOUT AUDIOGENIC EPILEPSY IN GOLDEN HAMSTERS
EFFECTS OF NOOTROPIC DRUGS OF PENTYLENETETRAZOL KINDLING IN RATS
INFLUENCE ON PENTYLENTETRAZOL KINDLING OF SOMATOSTATIN AND OF ITS COMBINATIONS WITH ANTICONVULSANTS
GABA-ERGIC AND EXICTATORY AMINO ACIDS TRANSMITTER MECHANISMS IN THE ANTICONVULSIVE ACTIVITY OF SOME BARBITURATES
STUDY OF ALGESIA AND MOTILITY IN RATS OF DIFFERENT AGES
THE AMPA ANTAGONIST NBQX DOES NOT ALTER THE MOTOR RESPONSE INDUCED BY SELECTIVE DOPAMINE AGONISTS IN MPTP-MONKEYS
THE INFLUENCE OF LONG-TERM HALOPERIDOL OR FLUPHENAZINE TREATMENTS ON STRIATAL DOPAMINERGIC AND NIGRAL GABA-ERGIC FUNCTIONS
NEUROPSYCHOLOGICAL FINDINGS IN CLINICAL SUBTYPES OF TOURETTE SYNDROME
EEG CHANGES IN CEREBRAL PALSY PATIENTS DURING THE ACQUISITION OF NEW MOTOR SKILL BY MEANS OF EMG BFB TRAINING
STUDY ON THE ROLE OF ACCUMBENS GABA-B RECEPTORS IN THE REGULATION OF MUSCULE TONE
PROBABILISTIC APPROACHES TO QUANTITATIVE DESCRIPTION OF 3D-ARRANGEMENT OF IDENTIFIED CELL ELEMENTS FROM ELECTRON MICROGRAPHS
SURFACE TOPOGRAPHY OF HOLES IN NEURON PLASMALEMMA AS AN INDICATOR OF GLUTAMATE NEUROTOXIC EFFECTS IN HIPPOCAMPUS
FUNCTIONAL AND MORPHOLOGICAL MODIFICATIONS OF THE ACOUSTIC SYSTEM IN GOLDEN HAMSTERS GPG/VALL WITH AUDIOGENIC EPILEPSY
MUSCLE WEAKNESS AND CONTINUOUS EMG ACTIVITY IN SENILE RATS; AN ANIMAL MODEL OF SPASTICITY?
ASSESSING THE RELATIONSHIP BETWEEN MEMORY AND SEDATION IN HUMAN PERFORMANCE
PHARMACOLOGICAL SPECIFICITY OF SHORT TERM WORKING MEMORY IMPAIRMENTS IN RATS
OBJECT DISCRIMINATION IN THE RAT AS A SCREENING PROCEDURE FOR FAST INDENTIFICATION OF DRUGS MODULATING MEMORY
EFFECT OF 9-AMINO-1, 2, 3, 4-TETRAHYDROACRIDINE ON PASSIVE AVOIDANCE RETENTION AND SS-ADRENOCEPTOR LINKED CYCLIC AMP ACCUMULATION IN MIDDLE AGED RATS
VASOPRESSIN ALTERS PERFORMANCE BY AFFECTING NORADRENERGICALLY-MEDIATED MOTIVATIONAL PROCESSES IN RATS
NEURONAL RESCUE OF DAMAGED HIPPOCAMPAL NEURONS AFTER CHRONIC BRAIN ISCHEMIA
ALZHEIMER'S DISEASE
PICK'S DISEASE TYPE C. SOME CLINICAL DIFFERENTIATIONS OF CASES PRESENTING ADDED HYSTOPATHOLOGICAL LESIONS OF ALZHEIMER'S DISEASE
ANGIOTENSIN II DERIVED PEPTIDES WITHOUT PHE-8 BUT NOT WITHOUT PRO-7 -PHE-8 RETAIN PSYCHOACTIVE PROPERTIES OF THE PARENT OCTAPEPTIDE
HOT-PLATE LEARNING IN RATS OF DIFFERENT AGES AND STRAINS
BEHAVIOURAL AND BIOCHEMICAL EFFECTS OF STONE MAZE PERFORMANCE IN AGED RATS
INVOLVEMENT OF NORADRENALINE SSRECEPTOR IN ATTENTION IN THE MONGOLIAN GERBIL
LONG-TERM EFFECTS OF POSTNATAL CONSISTENT OR INCONSISTENT HANDLING AND/OR ENRICHED ENVIRONMENT ON ADULT EMOTIVITY, LEARNING AND RETENTION
BEHAVIOURAL EFFECTS OF NEONATAL METALLIC MERCURY EXPOSURE IN RATS
BEHAVIOURAL EFFECTS OF PRENATAL METALLIC MERCURY EXPOSURE IN RATS
NEUROTRANSMITTER RECEPTORS IN DOWN SYNDROME
RADIAL MAZE PERFORMANCE, NEOPHOBIA, AND CNS CHOLINERGIC ALTERATIONS AFTER PRENATAL OXAZEPAM IN MICE
IMPAIRMENT OF LEARNING AND MEMORY IN RATS NEONATALLY INJECTED WITH 6-HYDROXYDOPAMINE (6-OHDA). EFFECTS OF NOOTROPIC DRUGS
HIPPOCAMPAL CALCIUM CHENNALS
THE EFFECT OF ANTICHOLINERGIC AGENTS AND NMDA ANTAGONISTS ON A PIGEON DELAYED MATCHING TO POSITION TASK
INVOLVEMENT OF SEROTONERGIC NEURONAL SYSTEMS IN THE ANTIAMNESIC ACTION OF NAFTIDROFURYL OXALATE
DISTURBED GLUTAMATERGIC TRANSMISSION IN DEMENTIA
CLINICAL PARADIGMS FOR THE STUDY OF COGNITION ENHANCERS
ADAFENOXATE ABOLISHES THE AMNESIA INDUCED BY 6-OHDA NEONATAL TREATMENT IN RATS
PSYCHOTROPIC EFFECTS OF ANGIOTENSIN II AND ITS FRAGMENTS IN RATS
UP-REGULATION OF CENTRAL DIHYDROPIRIDINE BINDING SITES RESULTS IN HYPERALGESIA AND POTENTIATION OF APOMORPHINE HYPERACTIVITY
SPINALLY-LOCALIZED 5-HT1A RECEPTORS POST-SYNAPTIC TO 5-HT NEURONES MEDIATE SPONTANEOUS TAIL-FLICKS IN THE RAT
BENTAZEPAM DOSE RANGE FINDING STUDY IN DSM-III-R ANXIETY DISORDERS. RESULTS IN THE M. H. C. OF MANRESA (BARCELONA)
IS HINDLIMB SCRATCHING IN RATS A SUITABLE MODEL FOR IN VIVO SCREENING OF 5-HT1D AGONIST COMPOUNDS?
BENTAZEPAM VS. BROMAZEPAM IN ANXIETY DISORDERS (DSM-III)
5-HT. RECEPTOR REGULATION OF MALE RAT SEXUAL BEHAVIOUR - EFFECTS OF THE SELECTIVE 5-HT, RECEPTOR ANTAGONIST AMPEROZIDE
A MICROSTRUCTURAL ANALYSIS OF THE DOPAMINE D-2 AGONIST QUINPIROLE'S EFFECTS IN A FOOD PREFERENCE TEST
OPPOSITE MODULATION OF 5-HT1A RECEPTOR-MEDIATED SPONTANEOUS TAIL- FLICKS BY, AND, RECEPTORS
HYPERTHERMIA INDUCED BY M-TRIFLUOROMETHYLPHENYLPIPERAZINE (TFMPP) IN HEAT ADAPTED RATS
DIFFERENTIAL ACTIVITIES OF (R)- AND (S)-ZACOPRIDE TO MODIFY EXTRACELLULAR LEVELS OF 5-HYDROXYTRYPTAMINE IN THE RAT FRONTAL CORTEX
ROLE OF OLFACTORY TUBERCLE AND NUCLEUS ACCUMBENS IN THE EFFECTS OF CLASSICAL AND ATYPICAL NEUROLEPTICS
PSYCHOPATHOLOGICAL DISORDERS IN CUSHING SYNDROM (CS)
EFFECTS OF NEUROCATIN ON THE RELEASE AND LEVEL OF SEROTONIN IN SYNAPTOSOMES FROM THE RAT BRAIN
THE EFFECT OF NEUROCATIN ON SEROTONIN METABOLISM IN SYNAPTOSOMES FROM RAT BRAIN
SEROTONIN 1. RECEPTOR ACTIVITY OF LISURIDE
SELECTIVE CCK RECEPTOR ANTAGONISTS AND MACRONUTRIENT CONSUMPTION IN THE RAT
EFFECTS OF MK-801, A NON-COMPETITIVE NMDA ANTAGONIST, ON AVOIDANCE AND ESCAPE BEHAVIOR IN MICE
GLYCINE-RELATED COMPOUNDS AS POTENTIAL NMDA-ANTAGONISTS. PRELIMINARY STRUCTURE-AFFINITY RELATIONSHIPS AND PHARMACOLOGICAL EVALUATION
PROTECTIVE EFFECTS OF NAFTIDROFURYL AGAINST HYPOXIA INDUCED DEATH
POSSIBLE ROLE OF PROLACTIN AS NEUROMODULATOR OF EXTRAHYPOTHALAMIC DOPAMINERGIC ACTIVITY
PROACTIVE INTERFERENCE IN A DELAYED MATCHING TO SAMPLE TASK IN THE RAT
TONIC IMMOBILITY (ANIMAL HYPNOSIS) IN TOADS MAY BE MEDIATED BY A CENTRAL CHOLINERGIC SYSTEM
LACK OF EVIDENCE FOR A ROLE OF DOPAMINE IN THE LONG-TERM DEPLETIONS OF SEROTONIN CAUSED BY FENFLURAMINE
EFFECT OF MK-801 ON DOPAMINERGIC SYSTEM IN THE RATS
ENVIRONMENTAL CUES DETERMINE THE REINFORCING PROPERTIES OF THE EXPERIENCE OF VICTORY IN MALE MICE
PONTENTIATION OF TONIC IMMOBILITY (ANIMAL HYPNOSIS) BY CHOLINERGIC STIMULATION OF THE PARABRACHIAL REGION
INTERACTION OF 5-HT. AGONISTS AND ANTAGONISTS AT ADRENOCEPTORS IN THE RAT
THE EFFECT OF THE D2 DOPAMINE AGONIST, QUINPIROLE, ON SCHEDULE-INDUCED LEVER PRESSING AND LICKING BEHAVIOUR IN RATS
D-FENFLURAMINE
THE RIVERMEAD BEHAVIOURAL MEMORY TEST BY B. WILSON, J. COCKBURN AND A. BADDELEY
THE EFFECTS OF ACUTE OR REPEATED CAFFEINE AND CLORAZEPATE ADMINISTRATION ON NACI SOLUTION INTAKE IN RATS
THE KINASE C ACTIVATION DOES NOT POTENTIATE FURTHER THE NORADRENALINE-INDUCEDCYCLIC AND RESPONSE AUGMENTED BY CHEMOSYMPATHECTOMY
INVOLVEMENT OF 5-HT4 RECEPTOR ON THE ABOMASAL AND DUODENAL MOTOR RESPONSES INDUCED BY SEROTONIN IN SHEEP
ACTIVATION OF SEROTONIN 5-HT, AND 5-HT, RECEPTORS OF GUINEA-PIG MYENTERIC NEURONS. THE ROLE OF NEUROKININS AND ACETYLCHOLINE
ACTIVATION OF PHOSPHOLIPASE C (PLC) BY CARBACHOL IN MEMBRANES OF RAT CEREBRAL CORTEX. EVIDENCE FOR A DISTINCT COUPLING OF M, AND M, TO THE PUTATIVE G-PROTEIN
THE ROLE OF SEROTONERGIC, ADRENERGIC AND DOPAMINERGIC MECHANISMS FOR INHIBITION OF FOOT SHOCK-INDUCED ULTRASONIC VOCALIZATION IN ADULT MALE RATS
INTRACORTCAL NEUROPEPTIDE Y ENHANCES LOCOMOTOR AND OPEN FIELD ACTIVITY IN THE RAT
EFFECTS OF SYSTEMATICALLY ADMINISTERED POLYAMINES /PA/ ON MORPHINE MOR ANALGESIA IN RATS
BEHAVIORAL EVIDENCE FOR THE EXISTENCE OF “ANTI-ANALGESIA” SYSTEMS
THE INFLUENCE OF IPSAPIRONE ON THE CONDITIONED SUPPRESSION OF THE AMBULATORY ACTIVITY OF RATS
INDEX